SectorBiological Technology
Established Date24/03/2006
Listing Date22/10/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees46
Fiscal Year Ends31/12
Security TypeCommon stock
Office address345 Park Avenue South, 3rd Floor, New York, NY 10010
Business
IntroductionProtara Therapeutics, Inc., was originally incorporated in Delaware on March 24, 2006. The company is a clinical-stage biopharmaceutical company based in New York City that advances transformative therapies for the treatment of cancer and rare diseases. The company's product portfolio includes two development projects utilizing TARA-002, an investigational cell therapy based on the broad immune-enhancing agent OK-432, which was originally granted marketing authorization by the Ministry of Health and Welfare of Japan as an immune-enhancing cancer treatment agent.
